Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 1 / 11 Update Summary Entity name RADIOPHARM THERANOSTICS LIMITED Announcement Type Update to previous announcement Date of this announcement 5/8/2026 Reason for update to a previous announcement...
Update - Proposed issue of securities - RAD
Filed with ASX ·
6ix hasn’t read this filing yet.
Radiopharm Theranostics Limited on 6ix
Earlier from Radiopharm Theranostics
- Application for quotation of securities - RAD
- Quarterly Activities/Appendix 4C Cash Flow Report
- Change in substantial holding
- Target market determination (TMD)
- Prospectus
Later from Radiopharm Theranostics
- Share Purchase Plan - Now Open
- Notice of Extraordinary General Meeting and Proxy Form
- RAD to meet with US FDA to align on RAD 101 Phase 3 Trial
- Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases
- RAD advances to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Trial
Follow Radiopharm Theranostics into a list and get an email when it puts out news.
Follow Radiopharm Theranostics